Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
measured Hugo Gene Rank description expected final
Results: HTML CSV LaTeX
Showing element 2658 to 2707 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
final\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.35534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SART1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
457\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T CELLS 1; U4/U6.U5 TRI-SNRNP-ASSOCIATED 110 KDA PROTEIN; IGE AUTOANTIGEN; SART1(259) PROTEIN; SART1(800) PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.28928\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.275611194\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.355425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1967\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"ADENYLATE KINASE ISOENZYME 4, MITOCHONDRIAL (EC 2.7.4.3) (ATP-AMP TRANSPHOSPHORYLASE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.53719\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.231217351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.355846\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
246\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"5'-AMP-ACTIVATED PROTEIN KINASE, BETA-1 SUBUNIT (AMPK BETA-1 CHAIN) (AMPKB). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13895\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.312433382\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.355858\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARPC1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
724\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 1A (SOP2-LIKE PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3445\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.264676832\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.35663\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HNRPK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
860\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K (HNRNP K) (DC-STRETCH BINDING PROTEIN) (CSBP) (TRANSFORMATION UPREGULATED NUCLEAR PROTEIN) (TUNP). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.36939\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.260429826\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.356784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.28488\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.277678849\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.357172\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
N6AMT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2412\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PUTATIVE N6-DNA-METHYLTRANSFERASE (EC 2.1.1.-) (PROTEIN PRED28) (M.HSAHEMK2P). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.63578\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.218349656\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.357744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP6V1B2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1744\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"VACUOLAR ATP SYNTHASE SUBUNIT B, BRAIN ISOFORM (EC 3.6.3.14) (V-ATPASE B2 SUBUNIT) (VACUOLAR PROTON PUMP B ISOFORM 2) (ENDOMEMBRANE PROTON PUMP 58 KDA SUBUNIT) (HO57). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.51127\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.236717463\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.357881\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
995\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
TRANSDUCIN-LIKE ENHANCER PROTEIN 1 (ESG1). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.40331\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.255026331\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.35972\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KPNB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1424\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
IMPORTIN BETA-1 SUBUNIT (KARYOPHERIN BETA-1 SUBUNIT) (NUCLEAR FACTOR P97) (IMPORTIN 90). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.4749\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.243894501\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.361623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF2S3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1397\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 2 SUBUNIT 3 (EUKARYOTIC TRANSLATION INITIATION FACTOR 2 GAMMA SUBUNIT) (EIF-2-GAMMA). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.48057\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.244245797\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.36177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNRPD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
123\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SMALL NUCLEAR RIBONUCLEOPROTEIN SM D1 (SNRNP CORE PROTEIN D1) (SM-D1) (SM-D AUTOANTIGEN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00996\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.358202305\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.363013\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
787\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CBF1 INTERACTING COREPRESSOR. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.38457\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.262184649\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.363365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCND2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1243\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 2; VOLTAGE-SENSITIVE POTASSIUM CHANNEL; VOLTAGE-GATED POTASSIUM CHANNEL KV4.2. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.46751\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.24760649\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.363846\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2923\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CYCLIN-DEPENDENT KINASES REGULATORY SUBUNIT 1 (CKS-1) (SID1334) (PNAS-16 / PNAS-143). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.16723\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.167885273\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.364089\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPSF4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2741\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"CLEAVAGE AND POLYADENYLATION SPECIFIC FACTOR 4, 30KD SUBUNIT; CLEAVAGE-POLYADENYLATION SPECIFICITY FACTOR, 30KD; NO ARCHES-LIKE (ZEBRAFISH) ZINC FINGER PROTEIN; CLEAVAGE-POLYADENYLATION SPECIFICITY FACTOR. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.77759\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.204821697\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.364125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ERCC5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
DNA-REPAIR PROTEIN COMPLEMENTING XP-G CELLS (XERODERMA PIGMENTOSUM GROUP G COMPLEMENTING PROTEIN) (DNA EXCISION REPAIR PROTEIN ERCC-5). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.853699\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.426526211\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.365106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OSGEPL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1783\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PUTATIVE SIALOGLYCOPROTEASE TYPE 2. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.55176\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.235285096\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.365822\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
648\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RAN-BINDING PROTEIN 2-LIKE 1 ISOFORM 2; SPERM MEMBRANE PROTEIN BS-63; RAN-BINDING PROTEIN 2-LIKE 1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.365\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.268001465\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.366149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPSF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2740\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR, 100 KDA SUBUNIT (CPSF 100 KDA SUBUNIT) (FRAGMENT). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.78474\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.205155373\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.366428\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP5B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2262\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"ATP SYNTHASE BETA CHAIN, MITOCHONDRIAL PRECURSOR (EC 3.6.3.14). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.64277\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.223054962\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.366443\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NME3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2065\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
NUCLEOSIDE DIPHOSPHATE KINASE 3 (EC 2.7.4.6) (NDK 3) (NDP KINASE 3) (NM23-H3) (DR-NM23). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.59695\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.229464291\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.367035\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF3D\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
503\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 7 (EIF-3 ZETA) (EIF3 P66) (EIF3D). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.33921\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.274068294\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.367121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PFKP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2949\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"6-PHOSPHOFRUCTOKINASE, TYPE C (EC 2.7.1.11) (PHOSPHOFRUCTOKINASE 1) (PHOSPHOHEXOKINASE) (PHOSPHOFRUCTO-1-KINASE ISOZYME C) (PFK-C) (6-PHOSPHOFRUCTOKINASE, PLATELET TYPE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.42367\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.151473179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.367472\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIMT1L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"PROBABLE DIMETHYLADENOSINE TRANSFERASE (EC 2.1.1.-) (S- ADENOSYLMETHIONINE-6-N',N'-ADENOSYL(RRNA) DIMETHYLTRANSFERASE) (18S RRNA DIMETHYLASE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.54946\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.237161334\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.368426\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FNBP1L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
391\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.32182\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.278726302\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.368948\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SFRS10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
412\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARGININE/SERINE-RICH SPLICING FACTOR 10 (TRANSFORMER-2-BETA) (HTRA2- BETA) (TRANSFORMER 2 PROTEIN HOMOLOG) (SILICA-INDUCED PROTEIN 41) (RA301). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.32916\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.277579825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.369521\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ISL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2779\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
INSULIN GENE ENHANCER PROTEIN ISL-2 (ISLET-2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.8374\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.201110809\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.37085\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAD2L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1190\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
MITOTIC SPINDLE ASSEMBLY CHECKPOINT PROTEIN MAD2A (MAD2-LIKE 1) (HSMAD2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.49174\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.248602303\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.374541\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SF3A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
298\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SPLICING FACTOR 3A SUBUNIT 2 (SPLICEOSOME ASSOCIATED PROTEIN 62) (SAP 62) (SF3A66). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24681\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.300399419\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.374769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TIAL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
119\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
NUCLEOLYSIN TIAR (TIA-1 RELATED PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03782\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.361111753\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.374874\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LHX4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2078\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
LIM/HOMEOBOX PROTEIN LHX4. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.63637\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.229088776\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.375086\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
126\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
UBA/UBX 33.3 KDA PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05643\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.3550505\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.375423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DCTN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1694\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
DYNACTIN COMPLEX 50 KDA SUBUNIT (50 KDA DYNEIN-ASSOCIATED POLYPEPTIDE) (DYNAMITIN) (DCTN-50) (DYNACTIN 2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.57827\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.237869946\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.375556\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 5 (EIF-5). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.956345\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.392699287\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.376553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF5AP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1586\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 5A (EIF-5A) (EIF-4D) (REV- BINDING FACTOR). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.56403\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.24075817\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.377523\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAPOLG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2680\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
POLY(A) POLYMERASE GAMMA (EC 2.7.7.19) (PAP GAMMA) (POLYNUCLEOTIDE ADENYLYLTRANSFERASE GAMMA) (SRP RNA 3' ADENYLATING ENZYME). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.81111\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.20844841\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.378587\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DLGAP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
DISKS LARGE-ASSOCIATED PROTEIN 1 (DAP-1) (GUANYLATE KINASE-ASSOCIATED PROTEIN) (HGKAP) (SAP90/PSD-95-ASSOCIATED PROTEIN 1) (SAPAP1) (PSD- 95/SAP90 BINDING PROTEIN 1). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.920789\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.411154999\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
DLGAP4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
DISKS LARGE-ASSOCIATED PROTEIN 4 (DAP-4) (SAP90/PSD-95-ASSOCIATED PROTEIN 4) (SAPAP4) (PSD-95/SAP90 BINDING PROTEIN 4). \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.378654\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TATDN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1777\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CDA11 PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.60733\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.235579501\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.379284\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VAV1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
VAV PROTO-ONCOGENE. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01082\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.375224076\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.379312\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UFD1L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
374\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
UBIQUITIN FUSION DEGRADATION PROTEIN 1 HOMOLOG (UB FUSION PROTEIN 1). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.35854\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.279205618\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.379831\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SETMAR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3014\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SET DOMAIN AND MARINER TRANSPOSASE FUSION GENE. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.11762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.121833642\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.380273\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VAV3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
VAV-3 PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.015\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.374653202\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.38076\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDHA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2025\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"PYRUVATE DEHYDROGENASE E1 COMPONENT ALPHA SUBUNIT, SOMATIC FORM, MITOCHONDRIAL PRECURSOR (EC 1.2.4.1) (PDHE1-A TYPE I). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.65321\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.230315568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.381101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
721\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
DJ470L14.3 (NOVEL PROTEIN SIMILAR TO THE ARP2/3 PROTEIN COMPLEX SUBUNIT P21-ARC (ARC21)). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.43987\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.264677367\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.382713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ERCC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2750\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
TFIIH BASAL TRANSCRIPTION FACTOR COMPLEX HELICASE SUBUNIT (EC 3.6.1.-) (DNA-REPAIR PROTEIN COMPLEMENTING XP-D CELLS) (XERODERMA PIGMENTOSUM GROUP D COMPLEMENTING PROTEIN) (CXPD) (DNA EXCISION REPAIR PROTEIN ERCC-2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.87606\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.203998273\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.383112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TAF9B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2675\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"TBP-ASSOCIATED FACTOR 9L; NEURONAL CELL DEATH-RELATED PROTEIN; TAF9-LIKE RNA POLYMERASE II, TATA BOX BINDING PROTEIN (TBP)-ASSOCIATED FACTOR, 31 KD; NEURONAL CELL DEATH-RELATED GENE IN NEURON-7; TRANSCRIPTION ASSOCIATED FACTOR TAFII31L; TRANSCRIPTION INIT"\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.83532\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.208743979\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.383414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WDR3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1454\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
WD-REPEAT PROTEIN 3. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.57686\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.243150311\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.383439\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP5A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2562\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"ATP SYNTHASE ALPHA CHAIN, MITOCHONDRIAL PRECURSOR (EC 3.6.3.14). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.79234\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.213932066\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/